Recent Blog Posts

Lorem Ipsum has been the industry's standard dummy text.

Showing posts from September, 2024Show all
CDSCO Releases Draft Guidelines on Good Clinical Practices
Immunotherapy after surgery may improve  survival in people with high-risk bladder cancer: NEJM
DoP releases Uniform Code for Pharmaceutical Marketing Practices 2024
Robot-Assisted Fixation Outperforms Traditional Methods for Calcaneal Fractures, Study Finds
Menstrual cycle may influence spread of mutant cells in mammary tissue, suggests research
New gene therapy offers promising  treatment for glaucoma as well as AMD: Study
Mirtazapine found ineffective in reducing breathlessness in respiratory disease patients in phase 3 trial
NPPA Revises and Fixes Ceiling Price of Chloroquine Tablet 150 mg
Eli Lilly invests $1.8 bln in Ireland sites to scale up Alzheimer's, obesity drug production
Kerala: Newborn, mother die at private Medical College; probe ordered
Women with disabilities at higher risk of SMM during delivery compared with those without disabilities: Study
CDSCO Approves safety, efficacy data with DMC report for Novartis' antimalarial drug Cipargamin
Continuous Terlipressin Infusion Improves Muscle Strength and Reduces Ascites in Cirrhosis: Study
Medical clowns shorten hospital stays for children with pneumonia,  finds study
Early Epoprostenol Use Effectively Treats Pulmonary Hypertension in Congenital Diaphragmatic Hernia: Study
Study Links PTSD Dimensions to Menopause-Related Health Issues in Midlife Women Veterans
CDSCO issues Cancelled permission List manufacturers
Eating disorder risks elevated among women with PCOS,  reports study
USFDA classifies Jubilant HollisterStier Spokane facility as VAI
Surgical Management bests Medical Therapy for Gynecomastia in Partial Androgen Insensitivity Syndrome: Study
Submit Phase I/Phase II clinical trial data: CDSCO Panel Tells Mankind on Dydrogesterone Injection 5mg/ml
CDSCO issues Cancelled Lincence List of importers